Key Drivers
- Strong EBITDA
- High leverage
- Low net margin
AIAI Summary
LXU's business is shifting from a low‑ROE, capital‑intensive commodity chemical profile to an EBITDA‑led operational recovery that can materially de‑risk leverage and unlock tax‑asset value—however, investors should require sustained adjusted EBITDA converting into FCF and clear deleveraging (or CCS permitting with committed offtake) before treating the recent price rally as a durable inflection.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong EBITDA
- •High leverage
- •Low net margin
LXU produces strong EBITDA and positive free cash flow and liquidity but low net margins, heavy capex and near‑term leverage materially compress returns and create mixed valuation signals.
Price Behavior
Key Price Behavior Insights:
- •Strong momentum
- •Extended/overbought
- •Watch for reversal
LXU is in a strong short-term uptrend—trading ~14% above its last-month 21-day SMA after a rapid ~54% run, with near-term resistance ~$14.90–$15.44 and support around $11.50–$12.80, so watch for momentum weakening or a pullback.
Sharp ~54% rise from $10.04 to $15.44 indicating elevated short-term volatility and pullback risk
Sentiment & News
Key News Insights:
- •Revenue rebound
- •EBITDA growth
- •Poison‑pill protection
LSB Industries (LXU) delivered stronger FY25/Q4 results with rising EBITDA, a swing to net income, bullish 2026 volume outlook, and a poison‑pill tied to large tax NOLs that renewed analyst/investor focus.
The operational recovery plus tax‑asset defense should stabilize shareholder value and deter hostile bids while keeping analyst attention on fundamentals
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings